• 1
    Meier, U., Gressner, AM (2004) Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 50: 15111525.
  • 2
    Kim, S., Moustaid-Moussa, N. (2000) Secretory, endocrine, and autocrine/paracrine function of the adipocyte. J Nutr. 130: 3110S3115S.
  • 3
    Steppan, C. M., Bailey, S. T., Bhat, S., et al (2001) The hormone resistin links obesity to diabetes. Nature 409: 292293.
  • 4
    Moon, B., Kwan, J. J., Duddy, N., Sweeney, G., Begum, N. (2003) Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am J Physiol. 285: E106E115.
  • 5
    Pravenec, M., Kazdova, L., Landa, V., et al (2003) Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem. 278: 4520945215.
  • 6
    Lee, J. H., Chan, J. L., Yianakouris, N., et al (2003) Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 88: 48484856.
  • 7
    Savage, D. B., Sewter, C. P., Klenk, E. S., et al (2001) Resistin/FIZZ3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50: 21992202.
  • 8
    Steppan, C. M., Brown, E. J., Wright, C. M., et al (2001) A family of tissue-specific resistin-like molecules. PNAS 98: 502506.
  • 9
    Oh, K. W., Lee, W. Y., Rhee, E. J., et al (2005) The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol. 63: 131138.
  • 10
    Palanivel, R., Sweeney, G. (2005) Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin. FEBS Lett. 579: 50495054.
  • 11
    Bouchard, L., Weisnagel, S. J., Engert, J. C., et al (2004) Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Quebec Family Study. J Endocrinol Invest. 27: 10031009.
  • 12
    Wang, H., Chu, W. C., Hemphill, C., Elbein, SC (2002) Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab. 87: 25202524.
  • 13
    Osawa, H., Onuma, H., Murakami, A., et al (2002) Systematic search for single nucleotide polymorphisms in the resistin gene. Diabetes 51: 863866.
  • 14
    Osawa, H., Yamada, K., Onuma, H., et al (2004) The G/G genotype of a resistin single-nucleotide polymorphism at −420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet. 75: 678686.
  • 15
    Ma, X., Warram, J. H., Trischitta, V., Doria, A. (2002) Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J Clin Endocrinol Metab. 87: 44074410.
  • 16
    Smith, S. R., Bai, F., Charbonneau, C., Janderova, L., Argyropoulos, G. (2003) A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52: 16111618.
  • 17
    Pizzuti, A., Argiolas, A., Di Paola, R., et al (2005) An ATG repeat in the 3′-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J Clin Endocrinol Metab. 87: 44034406.
  • 18
    Conneely, K. N., Silander, K., Scott, L. J., et al (2004) Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 47: 17821788.
  • 19
    Mattevi, V. S., Zembrzuski, V. M., Hutz, MH (2004) A resistin gene polymorphism is associated with body mass index in women. Hum Genet. 115: 208212.
  • 20
    Engert, J. C., Vohl, M. C., Williams, S. M., et al (2002) 5′ Flanking variants of resistin are associated with obesity. Diabetes 51: 16291634.
  • 21
    Thompson, P. D., Moyna, N., Seip, R., et al (2004) Functional polymorphisms associated with human muscle size and strength. Med Sci Sports Exerc. 36: 11321139.
  • 22
    American College of Sports Medicine (2000) ACSM's Guidelines for Exercise Testing and Prescription Lippincott Williams & Wilkins Philadelphia, PA.
  • 23
    Baechle, TR (1994) Essentials of Strength Training and Conditioning Human Kinetics Champaign, IL.
  • 24
    Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report (1998) National Heart, Lung, and Blood Institute National Institute for Diabetes and Digestive and Kidney Diseases Bethesda, MD.
  • 25
    Chung, S. S., Choi, H. H., Kim, K. W., Cho, Y. M., Lee, H. K., Park, KS (2005) Regulation of human resistin gene expression in cell systems: an important role of stimulatory protein 1 interaction with a common promoter polymorphic site. Diabetologia 48: 11501158.
  • 26
    Cho, Y. M., Youn, B. S., Chung, S. S., et al (2004) Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47: 55965.
  • 27
    Banerjee, R. R., Rangwala, S. M., Shapiro, J. S., et al (2004) Regulation of fasted blood glucose by resistin. Science 303: 11951198.
  • 28
    Kunnari, A., Ukkola, O., Kesaniemi, YA (2005) Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients. Diabet Med. 22: 583589.
  • 29
    Barb, D., Wadhwa, S. G., Kratzsch, J., et al (2005) Circulating resistin levels are not associated with fat redistribution, insulin resistance or metabolic profile in patients with the highly active antiretroviral therapy (HAART)-induced metabolic syndrome. J Clin Endocrinol Metab. 90: 53245328.
  • 30
    Yannakoulia, M., Yiannakouris, N., Bluher, S., Matalas, A., Klimis-Zacas, D., Mantzoros, CS (2003) Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab. 88: 17301736.
  • 31
    Schaffler, A., Buchler, C., Muller-Ladner, U., et al (2004) Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res. 36: 702707.
  • 32
    Huang, S. W., Seow, K. M., Ho, L. T., et al (2005) Resistin mRNA levels are downregulated by estrogen in vivo and in vitro. FEBS Letters 579: 449454.
  • 33
    Song, H., Shojima, N., Sakoda, H., et al (2002) Resistin is regulated by C/EBPs, PPARs, and signal-transducing molecules. Biochem Biophys Res Commun. 299: 291298.
  • 34
    Patel, L., Buckels, A. C., Kinghorn, I. J., et al (2003) Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 300: 472476.
  • 35
    Calabro, P., Samudio, I., Willerson, J. T., Yeh, ET (2004) Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 110: 33353340.
  • 36
    Lecka-Czernik, B., Moerman, E. J., Grant, D. F., Lehmann, J. M., Manolagas, S. C., Jilka, RL (2002) Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 143: 23762384.